P839: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN SHOW IMPROVEMENTS IN D-DIMER NORMALIZATION AND DECREASE IN INCIDENCE OF THROMBOSIS

• I. Weitz,
• M. Al-Adhami,
• J. Min,
• E. Persson,
• M. Yeh,
• J. Savage,
• D. Dingli

Affiliations

I. Weitz

1 Jane Anne Nohl Division of Hematology, Keck-USC School of Medicine, Los Angeles

M. Al-Adhami

2 Apellis Pharmaceuticals, Waltham, United States of America

J. Min

2 Apellis Pharmaceuticals, Waltham, United States of America

E. Persson

3 Swedish Orphan Biovitrum AB, Stockholm, Sweden

M. Yeh

2 Apellis Pharmaceuticals, Waltham, United States of America

J. Savage

2 Apellis Pharmaceuticals, Waltham, United States of America

D. Dingli

4 Mayo Clinic, Rochester, United States of America